Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

Area of Science:

• Gynecologic Oncology
• Urogynecology
• Medical Guidelines

Background:

• Endometrial cancer is the most common female genital tract malignancy in the United States.
• In 2022, an estimated 65,950 new cases and 12,550 deaths were projected.
• Endometrial carcinoma encompasses pure endometrioid and high-risk subtypes.

Purpose of the Study:

• To provide guidance on the diagnosis, staging, and management of pure endometrioid carcinoma.
• To present a focused selection from the NCCN Guidelines for Uterine Neoplasms.
• To offer accessible information for healthcare professionals and patients.

Main Methods:

• Review of the NCCN Guidelines for Uterine Neoplasms.
• Focus on diagnostic criteria for pure endometrioid carcinoma.
• Outline of staging and management strategies.

Main Results:

• Pure endometrioid carcinoma is a distinct subtype requiring specific diagnostic and management protocols.
• High-risk endometrial histologies and sarcomas represent less common but significant variations.
• The NCCN Guidelines offer a comprehensive framework for patient care.

Conclusions:

• Accurate diagnosis and staging are crucial for effective management of endometrial cancer.
• This guideline selection provides essential information for pure endometrioid carcinoma.
• Adherence to established guidelines ensures optimal patient outcomes.